Researchers used computational methods to design a multi-epitope peptide vaccine targeting essential proteins of the antibiotic-resistant pathogen Brevundimonas subvibrioides.
Entirely in silico designThe vaccine was designed using computational proteomics and immunoinformatics without any laboratory experiments
What the researchers found
A multi-epitope vaccine candidate was designed using subtractive proteomics and immunoinformatics targeting essential hypothetical proteins of antibiotic-resistant B. subvibrioides.
Why it matters
Antibiotic resistance is rendering current treatments ineffective against Brevundimonas infections. A vaccine approach could prevent infections entirely, bypassing the resistance problem.
The numbers in context
15 essential hypothetical proteins from DEG database. Multi-server functional annotation, physicochemical characterization, and non-homology analysis performed.
How the study worked
In silico study combining subtractive proteomics (to identify essential non-human-homologous bacterial proteins) with immunoinformatics (to predict immunogenic epitopes and design a multi-epitope vaccine construct).
Who was studied
Not applicable (vaccine design)
What this study cannot tell us
Entirely computational — no laboratory validation, animal testing, or clinical data. The predicted immunogenicity and protective efficacy remain theoretical until experimentally confirmed.
How to read the evidence
Computational study only — no experimental validation. Represents the earliest stage of vaccine development and requires extensive laboratory and clinical testing before any conclusions about real-world efficacy.
When this study was published
Published in 2025, using current bioinformatics tools for vaccine design against an emerging pathogen.
The bigger picture
This work exemplifies how computational vaccinology can accelerate vaccine design against emerging antibiotic-resistant pathogens, potentially shortening the path from target identification to candidate selection.
Questions still open
- Will the computationally designed vaccine candidate produce the predicted immune response in laboratory and animal studies?
- Can this in silico pipeline be applied to other antibiotic-resistant pathogens?
Common questions
What is a multi-epitope vaccine?
What is Brevundimonas and why does it need a vaccine?
Read the original research
An in silico vaccinomics strategy to develop multiepitope vaccine using essential hypothetical protein as a target against Brevundimonas subvibrioides: A combined subtractive proteomics and immunoinformatics approach.
Microbial pathogenesis, 205, 107651
Citation
Paul, Ishani; Roy, Alankar; Sarkar, Tista; Dutta, Shounak; Ray, Sujay. (2025). An in silico vaccinomics strategy to develop multiepitope vaccine using essential hypothetical protein as a target against Brevundimonas subvibrioides: A combined subtractive proteomics and immunoinformatics approach.. Microbial pathogenesis, 205, 107651. https://doi.org/10.1016/j.micpath.2025.107651